The CD44 Receptor of Lymphoma Cells: Structure-Function Relationships and Mechanism of Activation

References

• Bartolazzi A., Jackson D. G., Bennett K. L., Aruffo A., Dickinson R., Shields J., Whittle N., Stamenkovic I. Regulation of growth and dissemination of a human lymphoma by CD44 splice variants. J. Cell Sci. 1995; 108: 1723–1733
   PubMed Web of Science ®Google Scholar
• Bennett K. L., Modrell B., Greenfield B., Bartolazzi A., Stamenkovic I., Peach R., Jackson D. G., Spring F., Aruffo A. Regulation of CD44 binding to hyalur-onan by glycosylation of variably spliced exons. J. Cell Biol. 1995; 131: 1623–1633
   PubMed Web of Science ®Google Scholar
• Bourguignon L. Y.W., Lokeshwar V. B., Chen X., Kerrick W. G.L. Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44) cytoskeleton interaction. J. Immunol. 1993; 151: 6634–6644
   PubMed Web of Science ®Google Scholar
• Chomczynski P., Sacchi N. Single-step method of RNA isolation by acidic guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987; 162: 156–159
   PubMed Web of Science ®Google Scholar
• Coll M. J., Serratosa J., Bachs O., Gahmberg C. G., Enrich C. Calmodulin may decrease cell surface sialic acid and be involved in the expression of fibronectin during liver regeneration. FEBS Lett. 1986; 208: 418–422
   PubMed Web of Science ®Google Scholar
• Cummings R. D. Synthesis of asparagine-linked oligosaccharides: pathways, genetics, and metabolic regulation. Glycocconjugates, Composition, Structure and function, H. J. Allen, E. C. Kisailus. Marcel Dekker, Inc., New York 1992; 333–360
   Google Scholar
• de Belder A. N., Wik K. O. Preparation and properties of fluorescein-labelled hyaluronate. Carbohydr. Res. 1975; 44: 251–257
   PubMed Web of Science ®Google Scholar
• Edidin M., Wei T. Y. Diffusion rates of cell surface antigens of mouse-human heterokaryons. I. Analysis of the population. J. Cell Biol 1977; 75: 475–482
   PubMed Web of Science ®Google Scholar
• Edidin M. Patches, posts and fences: proteins and plasma membrane domains. Trends in Cell Biol. 1992; 2: 376–380
   PubMedGoogle Scholar
• Galluzo E., Albi N., Fiorucci S., Merigiola C, Ruggeri L., Tosti A., Grossi C. E., Velardi A. Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells. Eur. J. Immunol. 1995; 25: 2932–2939
   PubMed Web of Science ®Google Scholar
• Geppert T. D., Lipsky P. E. Association of various T cell-surface molecules with the cytoskeleton. J. Immunol. 1991; 146: 3298–3305
   PubMed Web of Science ®Google Scholar
• He Q., Lesley J., Hyman R., Ishihara K., Kincade P. W. Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition. J. Cell Biol. 1992; 119: 1711–1719
   PubMed Web of Science ®Google Scholar
• Heron D. S., Shinitzky M., Hershkowitz M., Samuel D. Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. Proc. Natl. Acad. Sci. USA 1980; 77: 7463–7467
   PubMed Web of Science ®Google Scholar
• Hyman R., Lesley J., Schulte R. Somatic cell mutants distinguish CD44 expression and hyaluronic acid binding. Immunogenetics 1991; 33: 392–395
   PubMed Web of Science ®Google Scholar
• Isacke C M. The role of the cytoplasmic domain in regulating CD44 function. J. Cell Sci. 1994; 107: 2353–2359
   PubMed Web of Science ®Google Scholar
• Jackson D. G., Bell J. I., Dickinson R., Timans J., Shields J., Whittle N. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J. Cell Biol 1995; 128: 673–685
   PubMed Web of Science ®Google Scholar
• Kalomiris E. L., Bourguignon L. Y.W. Lymphoma protein kinase C is associated with the transmembrane glycoprotein, GP85, and may function in GP85-Ankyrin binding. J. Biol. Chem. 1989; 264: 8113–8119
   PubMed Web of Science ®Google Scholar
• Katoh S., Zheng Z., Oritani K., Shimozato T., Kincade P. W. Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J. Exp. Med. 1995; 182: 419–429
   PubMed Web of Science ®Google Scholar
• Lee T. H., Wisniewski H. G., Vilcek J. A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44. J. Cell. Biol. 1992; 116: 545–557
   PubMed Web of Science ®Google Scholar
• Lesley J., He Q., Miyake K., Hamann A., Hyman R., Kincade P. W. Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody. J. Exp. Med. 1992; 175: 257–266
   PubMed Web of Science ®Google Scholar
• Lesley J., Hyman R., Kincade P. W. CD44 and its interaction with extracellular matrix. Adv. Immunol 1993a; 54: 271–335
   PubMed Web of Science ®Google Scholar
• Lesley J., Kincade P. W., Hyman R. Antibody-induced activation of the hyaluronan receptor function of CD44 requires multivalent binding by antibody. Eur. J. Immunol 1993b; 23, 1902–1909
   PubMed Web of Science ®Google Scholar
• Lesley J., English N., Perschl A., Gregoroff J., Hyman R. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J. Exp. Med. 1995; 182: 431–437
   PubMed Web of Science ®Google Scholar
• Liao H.-X., Levesque M. C., Patton K., Bergamo B., Jones D., Moody M. A., Telen M. J., Haynes B. F. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies. J. Immunol 1993; 151: 6490–6499
   PubMed Web of Science ®Google Scholar
• Liu D., Sy M.-S. A cystein residue located in the transmembrane domain of CD44 is important in binding of CD44 to hyaluronic acid. J. Exp. Med. 1996; 183, 1987-1994
   Web of Science ®Google Scholar
• Lokeshwar V. B., Fregien N., Bourguignon L. Y.W. Ankyrin-binding domain of CD44 (GP85) is required for the expression of hyaluronic acid-mediated adhesion function. J. Cell Biol. 1994; 126: 1099–1109
   PubMed Web of Science ®Google Scholar
• Lugasi H., Hajos S., Murphy J. R., Strom T. B., Nichols J., Penarroja C., Naor D. Murine spontaneous T-cell leukemia constitutively expressing IL-2 receptor - a model for human T-cell malignancies expressing IL-2 receptor. Int. J. Cancer 1990; 45: 163–167
   PubMed Web of Science ®Google Scholar
• McLean I. W., Nakane P. K. Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelec-tron microscopy. J. Histochem. Cytochem. 1974; 22: 1077–1083
   PubMed Web of Science ®Google Scholar
• Miyake K., Medina K. L., Hayashi S.-L, Ono S., Hamaoka T., Kincade P. W. Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J. Exp. Med. 1990; 171: 477–488
   PubMed Web of Science ®Google Scholar
• Murakami S., Shimabukuro Y., Miki Y., Saho T., Hino E., Kasai D., Nozaki T., Kusumoto Y., Okada H. Inducible binding of human lymphocytes to hyaluronate via CD44 does not require cytoskeleton association but does require new protein synthesis. J. Immunol 1994; 152: 467–477
   PubMed Web of Science ®Google Scholar
• Nabi Z. F., Zucker-Franklin D., Baten A. Phorbol ester-induced loss of membrane sialic acid: implications for tumor cytolysis by natural killer cells. J. Leukoc. Biol 1989; 45: 183–188
   PubMed Web of Science ®Google Scholar
• Nakano T., Matsui T., Ota T. Benzyl-alpha-GalNAc inhibits sialylation of O-glycosidic sugar chains on CD44 and enhances experimental metastatic capacity in B16B16 melanoma cells. Anticancer Res. 1996; 16: 3577–3584
   PubMed Web of Science ®Google Scholar
• Naor D., Sionov Vogt R., Ish-Shalom D. CD44: structure, function, and association with the malignant process. Adv. Cancer Res. 1997; 71: 241–319
   PubMed Web of Science ®Google Scholar
• Nicolson G. L., Lacorbiere M., Eckhart W. Qualitative and quantitative interactions of lectins with untreated and neuraminidase-treated normal, wild-type, and temperature-sensitive polyoma-transformed fibroblasts. Biochemistry 1975; 14: 172–179
   PubMed Web of Science ®Google Scholar
• Ohyama Y., Kasai K., Nomoto H., Inoue Y. Frontal affinity chromatography of ovalbumin glycoas-paragines on a concanavalin A-sepharose column. J. Biol. Chem. 1985; 260: 6882–6887
   PubMed Web of Science ®Google Scholar
• Peach R. J., Hollenbaugh D., Stamenkovic I., Aruffo A. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J. Cell Biol 1993; 122: 257–264
   PubMed Web of Science ®Google Scholar
• Perschl A., Lesley J., English N., Trowbridge I., Hyman R. Role of CD44 cytoplasmic domain in hyaluronan binding. Eur. J. Immunol 1995; 25: 495–501
   PubMed Web of Science ®Google Scholar
• Pure E., Camp R. L., Peritt D., Panellieri R. A., Jr., Lazaar A. L., Nayak S. Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain. J. Exp. Med. 1995; 181: 55–62
   PubMed Web of Science ®Google Scholar
• Ruggiero R. A., Bustuoabad O. D., Bonfil R. D., Meiss R. P., Pasqualini C D. “Concomitant immunity” in murine tumours of non-detectable immunogenicity. Brit. J. Cancer 1985; 51: 37–48
   PubMed Web of Science ®Google Scholar
• Scott J. E. The precipitation of polyanions by long-chain aliphatic ammonium salts. Biochem. J. 1961; 81: 418–424
   PubMed Web of Science ®Google Scholar
• Sellers J. R., Cuda G., Wang F., Homsher E. Myosin-specific adaptations of the motility assay. Methods Cell Biol. 1993; 39: 23–49
   PubMed Web of Science ®Google Scholar
• Skelton T. P., Zeng C, Nocks A., Stamenkovic I. Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan. J. Cell Biol. 1998; 140: 431–446
   PubMed Web of Science ®Google Scholar
• Sleeman J. P., Arming S., Moll J. F., Hekele A., Rudy W., Sherman L. S., Kreil G., Ponla H., Herrich P. Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells. Cancer Res. 1996; 56: 3134–3141
   PubMed Web of Science ®Google Scholar
• Sleeman J. P., Moll J., Kondo K., Ponta H., Herrlich P. Variant exons v6 and v7 together expand the repertoire of glycosaminoglycans bound by CD44. J. Biol. Chem. 1997; 272: 31837–31844
   PubMed Web of Science ®Google Scholar
• Springer T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76: 301–314
   PubMed Web of Science ®Google Scholar
• Stamenkovic I., Aruffo A., Amiot M., Seed B. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyalur-onate-bearing cells. EMBO J. 1991; 10: 343–348
   PubMed Web of Science ®Google Scholar
• Sy M. S., Guo Y.-J., Stamenkovic I. Distinct effects of two CD44 isoforms on tumor growth. in riro. J. Exp. Med. 1991; 174: 859–866
   PubMed Web of Science ®Google Scholar
• Thomas L., Byers H. R., Vink J., Stamekovic I. CD44H regulates tumor cell migration on hyaluronale-coated substrate. J. Cell Biol. 1992; 118: 971–977
   PubMed Web of Science ®Google Scholar
• Trowbridge I. S., Lesley J., Schulte R., Hyman R., Trotter J. Biochemical characterization and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed in lymphoid tissues. Immunogenetics 1982; 15: 299–312
   PubMed Web of Science ®Google Scholar
• Uff C. R., Neame S. J., Isacke C M. Hyaluronan binding by CD44 is regulated by a phosphorylation-independent mechanism. Eur. J. Immunol. 1995; 25: 1883–1887
   PubMed Web of Science ®Google Scholar
• van derVoort R., Manten-Horst Smit E.L., Ostermann E., Van Den Berg F., Pals S. T. Binding of cell-surface expressed CD44 to hyaluronate is dependent on splicing and cell type. Biochem. Biophvs. Res. Commun. 1995; 214: 137–144
   PubMed Web of Science ®Google Scholar
• van Weering D. H.J., Baas P. D., Bos J. L. A PCR-based method for the analysis of human CD44 splice products. PCR Melh. Appl. 1993; 3: 100–106
   PubMedGoogle Scholar
• VogtSionov R., Naor D. Hyaluronan-independent lodgment of CD44+ lymphoma cells in lymphoid organs. Int. J. Cancer 1997; 71: 462–469
   PubMed Web of Science ®Google Scholar
• VogtSionov R., Naor D. Calcium- and calmodulin-dependent PMA-activation of CD44 adhesion molecule. Cell Adhesion Comm. 1998; 6: 503–523
   PubMedGoogle Scholar
• Yamada K. M., Miyamoto S. lntegrin transmembrane signaling and cytoskeletal control. Curr. Opin. Cell Biol. 1995; 7: 681–689
   PubMed Web of Science ®Google Scholar
• Zahalka Okon M.A.E., Naor D. Blocking lymphoma invasiveness with a monoclonal antibody directed against the β-chain of the leukocyte adhesion molecule (CD 18). J. Immunol. 1993; 150: 4466–4477
   PubMed Web of Science ®Google Scholar
• Zahalka M. A., Okon E., Gosslar U., Holzmann B., Naor D. Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-depen-dent. J. Immunol. 1995; 154: 5345–5355
   PubMed Web of Science ®Google Scholar
• Zheng Z., Cummings R. D., Pummill P. E., Kincade P. W. Growth as a solid tumor or reduced glucose concentrations in culture reversibly induce CD44-mediated hyaluronan recognition by Chinese hamster ovary cells. J. Clin. Invest. 1997; 100: 1217–1229
   PubMed Web of Science ®Google Scholar
• Ziomek C. A., Schulman S., Edidin M. Redistribution of membrane proteins in isolated mouse intestinal epithelial cells. J. Cell Biol. 1980; 86: 849–857
   PubMed Web of Science ®Google Scholar